Scientists at Northwestern University have identified a previously hidden toxic protein that may trigger Alzheimer’s disease ...

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

In the weeks leading up to Dec. 3, I imagined a fantastic headline: “Ozempic treats Alzheimer’s disease.” ...

Researchers have identified elusive DNA switches in brain support cells that influence genes tied to Alzheimer’s disease. When people think about DNA, they often picture genes that determine our ...

Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) by inhibiting semaphorin 4D (SEMA4D) induced pathology in brain, ...